Page URL: https://www.bionews.org.uk/page_88544

Late-onset Parkinson's gene link

29 October 2001
By BioNews
Appeared in BioNews 131

Researchers at DeCODE genetics, the Rekyavik-based company studying the genetic records of the Icelandic population, announced last week that it had discovered a gene linked to the main form of Parkinson's disease. The gene was found on a small section of chromosome one after a study of data from 51 Icelandic families.

The scientists plan to use the information to develop new diagnostic tests and new treatments for the condition, although these will be many years away. Kari Stefansson, the chief executive of DeCODE, said that the gene discovery goes against the more commonly held belief that Parkinson's has no identifiable genetic component. Genes have been found for rarer forms of the disease but this is the first time a gene has been identified as having a causal link to the late-onset form of the disease.

SOURCES & REFERENCES
Icelandic firm finds Parkinson's disease gene
Yahoo Daily News |  23 October 2001
Scientists find genetic key to Parkinson's
The Sunday Telegraph |  28 October 2001
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 May 2006 - by Dr Jess Buxton 
The UK's fertility treatment regulator has given the go-ahead for couples to test embryos to avoid passing on hereditary cancer. At its open meeting held on 10 May in Belfast, the Human Fertilisation and Embryology Authority (HFEA) accepted a recommendation from its ethics and law committee...
10 November 2005 - by BioNews 
The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public debate on testing embryos for 'lower penetrance', late onset genetic disorders. A discussion paper, entitled 'Choices and Boundaries', focuses both on genetic tests currently available, such as that for hereditary breast cancer, and possible future developments, such as...
11 August 2005 - by BioNews 
The UK's Human Fertilisation and Embryology Authority (HFEA) is to issue a public consultation on the use of preimplantation genetic diagnosis (PGD) for late-onset and 'lower penetrance' genetic disorders. The use of this technology to avoid later onset genetic conditions sparked debate recently, following the authority's decision to grant a...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.